- Nachrichtendetail
-
31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.051,030 | 28.06.24 22:17:37 | +0,370 | +0,04% | 1.052,250 | 1.052,100 | 1.054,810 | 1.051,030 |
